9QG-28980-46680
2 vaccinations
4 coded responses
23 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 986 / WA
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-04
Registered in v-safe
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Ear pruritus, Pruritus, Rash, Rash pruritic, Self-medication — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Itchy rash in distal forearm about 7 hours after the injection and some itchiness upper back and earlobe. Rash and itchiness resolved after taking Benadryl .MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Survey response — day 0, dose 2MedDRA: Product administered at inappropriate site — Feeling: Good · Site: PainFree text: The injection was given below the deltoid muscle. Is it still effective?MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Immunisation reaction, Lymphadenopathy, Office visit, Skin discolouration — Feeling: Good · Site: Pain, Redness, Itching · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Redness spread to a larger area in the shoulder and to side of neck. Noticed lacey pattern on forearms. Went to walk in clinic. Told no infection. Have swollen lymph glands and am having a robust immune responseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-01
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-05-08
-
2021-05-15
Survey response — day 21, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: New swollen glands and soreness in the bilateral axillary areas.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-24
- 2021-05-29
- 2021-06-05
- 2021-07-26
- 2021-10-25
-
2022-04-14
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Itchy rash in distal forearm about 7 hours after the injection and some itchiness upper back and earlobe. Rash and itchiness resolved after taking Benadryl .
Release 7 — day 0, dose 2
Systemic reaction (other): The injection was given below the deltoid muscle. Is it still effective?
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Redness spread to a larger area in the shoulder and to side of neck. Noticed lacey pattern on forearms. Went to walk in clinic. Told no infection. Have swollen lymph glands and am having a robust immune response
Release 8 — day 21, dose 2
Symptoms: New swollen glands and soreness in the bilateral axillary areas.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Axillary pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Ear pruritus | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Immunisation reaction | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Office visit | ✓ | ✓ | ✓ |
| SRO | Product administered at inappropriate site | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Skin discolouration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release